Non-Exclusive License Grant by CDIC Sample Clauses

Non-Exclusive License Grant by CDIC. CDIC hereby grants to Vasomedical a non-exclusive, perpetual (subject to termination as provided in this Agreement), non-transferable, worldwide license, with the right to sub-license only to purchasers/end-users of the Equipment, to use, install, test, adapt, and transfer and otherwise distribute the core software used for processing waveform data and calculating hemodynamic parameters (the “DSP Code”) in the Modules in connection with the manufacture, assembly, test, lease, sale, license, transfer or other distribution by or for Vasomedical of the Equipment under this Agreement. In the event Vasomedical elects to manufacture the ICG Board itself, the license to the DSP Code shall be to use, install, test, adapt, and transfer and otherwise distribute the DSP Code in the ICG Boards connection with the manufacture, assembly, test, lease, sale, license, transfer or other distribution by or for Vasomedical of the Equipment under this Agreement. Except for this express license by CDIC, Vasomedical shall not disclose, furnish, transfer, distribute or otherwise make available the DSP Code, or any portion thereof, in any form to any third party and shall not duplicate DSP Code or any part of any of same. Title to and ownership of any and all proprietary rights in or to the DSP Code shall at all times remain with CDIC or its licensor(s). Nothing in this Agreement shall be construed as a sale or any other transfer of any title in the DSP Code. All references in this Agreement to sale, resale or purchase of Modules, or the respective components thereof, or references of like effect, shall, with respect to the DSP Code, mean licenses or sublicenses of the DSP Code pursuant to this Section 3.6. Vasomedical shall not disassemble, decompile or otherwise reverse-engineer the DSP Code or any part of any of same. Vasomedical shall retain and shall not alter or obscure any notices, markings or other insignia affixed to the DSP Code or any part of any of same, as such notices, markings and/or insignia may be affixed as of the time Vasomedical receives same.
Sample 1
AutoNDA by SimpleDocs

Related to Non-Exclusive License Grant by CDIC

  • Non-Exclusive License Grant Subject to the terms and conditions of this Agreement, Takeda hereby grants to Licensee a non-exclusive, sublicensable (subject to Section 3.3 (Sublicensing)) right and license under the Takeda Technology and Takeda’s interest in the Joint Technology to: (a) Develop the TAK-385 Licensed Compound and TAK-385 Licensed Products in the Men’s Health Field in the Takeda Territory solely for the purpose of Exploiting such Licensed Products in the Field in the Licensee Territory, or as required in order for Licensee to comply with its diligence obligations set forth in Section 5.2 (Development Diligence Obligations) and (b) Manufacture the TAK-385 Licensed Compound and TAK-385 Licensed Products in the Takeda Territory.

  • Exclusive License Grant Subject to the terms and conditions of this Agreement, Licensee hereby grants to Takeda an exclusive, sublicensable (subject to Section 3.3 (Sublicensing)), royalty-bearing right and license under the Licensee Technology and Licensee’s interest in the Joint Technology to Exploit the TAK-385 Licensed Compound and TAK-385 Licensed Products in the Field in the Takeda Territory.

  • Non-Exclusive License NCPS grants Company a revocable, non-exclusive, non-transferable and non-sublicensable license during the Term to view-only access the PPEX ATS through the PPEX Site and its related software and other applications and technology for the sole purpose of viewing information about Company and Company Securities and Trades of Company Securities. This license is in addition to the license Company has and is required to maintain during the Term (as defined below) with NCPS’s affiliate, North Capital Investment Technology, Inc., for TransactAPI pursuant to a separate Software and Services License Agreement (“SSLA”). The technology covered by the licenses outlined in this Section 2 is collectively referred to herein as the “Technology”.

  • Exclusive License Licensor hereby grants to Licensee and Licensee hereby accepts from Licensor, upon the terms and conditions herein specified, a sole and exclusive license under the Licensed Patent Rights in the Territory, and in the Field of Use to develop, make, have made, import, have imported, use, offer to sell, sell and otherwise commercialize Licensed Product(s).

  • License Grant Subject to the terms and conditions of this Agreement, including the Retained Rights, Licensor hereby grants to Licensee an exclusive, sublicensable (as provided in Section 2.4 only), non-transferable (except as provided in Section 10.2), royalty-bearing, worldwide license, under the Licensed Patents to make, have made, use, import, sell, and offer for sale Licensed Products solely in the Field, including, for the avoidance of doubt, the right to conduct research and development.

  • Sublicense Grant Licensee will be entitled to grant Sublicenses to third parties under the license granted pursuant to Section 2.1 subject to the terms of this Section 2.3. Any such Sublicense shall be on terms and conditions in compliance with and not inconsistent with the terms of this Agreement. The grant of a Sublicense shall not in any way diminish or alter Licensee’s obligations under this Agreement.

  • Non-exclusivity of Rights Nothing in this Agreement shall prevent or limit the Executive's continuing or future participation in any plan, program, policy or practice provided by the Company or any of its affiliated companies and for which the Executive may qualify, nor, subject to Section 12(f), shall anything herein limit or otherwise affect such rights as the Executive may have under any contract or agreement with the Company or any of its affiliated companies. Amounts which are vested benefits or which the Executive is otherwise entitled to receive under any plan, policy, practice or program of or any contract or agreement with the Company or any of its affiliated companies at or subsequent to the Date of Termination shall be payable in accordance with such plan, policy, practice or program or contract or agreement except as explicitly modified by this Agreement.

  • Non-Exclusive Rights The provisions for indemnification of, and advancement of Expenses to, the Board Member set forth in this Agreement shall not be deemed exclusive of any other rights to which the Board Member may otherwise be entitled. Notwithstanding the previous sentence, the indemnification provided for in this Agreement is in lieu of, and not in addition to, the indemnification set forth in the Trust Instrument. The Fund shall not be liable under this Agreement to make any payment of amounts otherwise indemnifiable hereunder if and to the extent that the Board Member has otherwise actually received such payment under any insurance policy, contract, agreement or otherwise.

  • License Grants Subject to the terms of this Agreement, M.I.T. hereby grants to COMPANY and its AFFILIATES for the TERM a royalty-bearing license under the PATENT RIGHTS to develop, make, have made, use, sell, offer to sell, lease, and import LICENSED PRODUCTS in the FIELD in the TERRITORY and to develop and perform LICENSED PROCESSES in the FIELD in the TERRITORY.

  • Non-Exclusive Agreement The services of the Adviser to the Fund under this Agreement are not to be deemed exclusive, and the Adviser shall be free to render similar services or other services to others so long as its services hereunder are not impaired thereby.

Time is Money Join Law Insider Premium to draft better contracts faster.